<DOC>
	<DOCNO>NCT00660660</DOCNO>
	<brief_summary>The purpose research study compare safety effectiveness ( well medicine work ) esomeprazole ( study drug ) placebo ( capsule contain medication ) take daily relieve nighttime heartburn problem sleep patient gastroesophageal reflux disease ( GERD ) .</brief_summary>
	<brief_title>Local Phase IV , Gastroesophageal Reflux Disease ( GERD ) Sleep Study US</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>Prior runin period , history heartburn acid regurgitation 3 month long history EE ; Prior runin period , nighttime heartburn average least 2 3 time per week ; Prior runin period , history sleep disturbance associate GERD 1 month ; Any condition GERD either primary cause , significant contributor , patient 's sleep disturbance Sleep medication ( include overthecounter ) , antihistamine , benzodiazepine , antianxiety medication use stable ( either dose regularity ) least 3 month expect remain stable patient 's participation study . Patients stable regimen , whose regimen also expect remain stable throughout study , eligible participation ; Proton Pump Inhibitor ( PPI ) use within 1 week prior Screening . The allowable acid modify rescue medication GELUSIL® runin period . Only study medication rescue medication ( GELUSIL® ) allow treatment period treatment acid mediate symptom</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>GERD</keyword>
	<keyword>Esophageal Reflux</keyword>
	<keyword>Gastro-Esophageal Reflux</keyword>
	<keyword>Regurgitation</keyword>
	<keyword>Gastric</keyword>
</DOC>